i-base

News

Fit for Purpose: treatment optimisation reports (2012 – 2018)

– Fit for Purpose is an i-Base publication about HIV treatment strategies for low and middle-income countries. The latest edition was launched at the AIDS 2018 conference in Amsterdam in July 2018. Read July 2018 edition online. This report is …

Adult and paediatric optimised ART trial tracker

Trial Tracker is a new i-Base resource publishes routinely updated tables on the web. This is freely available via i-Base’s Google Docs. Op ART trial tracker i-Base’s Op ART trial tracker follows research on optimised antiretroviral treatment for low- and …

AIDS 2018: early i-Base reports from Amsterdam

23 – 27 July 2018, Amsterdam Early reports i-Base reports, including from the HIV paediatric workshop held before AIDS 2018, will be added to the list of articles below. WHO recommends dolutegravir widely but women’s access will depend on contraception …

HTB: issue 12 online: DTG and preconception, AIDS 2018 and more (11 July 2018)

Contents online PDF of this issue Subscribe by email This HTB leads with a special report by Polly Clayden into the response to the recent safety alerts concerning dolutegravir (DTG) and its use preconception and a related article on balancing …

HIV pipeline 2018: new drugs in development 

Simon Collins, HIV i-Base This is the second year that i-Base has produced the HIV pipeline review as part of our Fit for Purpose report on HIV treatment optimisation. Two versions will be available: 1. The full version reports key …

PrEP – a pocket guide (2018)

Pocket PrEP is an A7-sized guide to PrEP in the UK. It is an introduction to how PrEP works and buying PrEP online. Download pocket PrEP – PDF (400 Kb) Order free printed copies More pocket ART pages PrEP stands for pre-exposure prophylaxis. It is …

HTB: issue 11 online (29 June 2018): darunavir/cobicistat alert, PK reports and more

Contents online PDF of this issue Subscribe by email This issue of HTB starts with a treatment alert stating that cobicistat boosted darunavir is contraindicated in pregnant women. This is based on significantly reduced plasma levels of darunavir and cobicistat …

HTB: issue 10 online (08 June 2018): DTG alert, PK reports and more

Darunavir and heart disease, a controversial review of PrEP, albuvirtide approved in China…

HTB: issue 9 online (21 May 2018): DTG alert and BHIVA/BASHH reports

Contents online PDF of this issue Subscribe by email This issue of HTB leads with worrying reports of a potential signal of neural tube defects in four women taking dolutegravir at the time of conception. Importantly, there is no signal …

Questions about U=U: what, when, who, why….?

The following questions provide more information about why an undetectable viral load stops HIV transmission (U=U). Download U=U Q&A factsheet (PDF) U=U posters and post cards for clinics. What is U=U? U=U is an abbreviation for: Undetectable = Untransmittable It means …

HTB: issue 8 online (1 May 2018): special BHIVA/BASHH conference issue

4th BHIVA/BASHH conference in Edinburgh… access to services, new guidelines, standards of care, WeLoveKissing…

HTB: issue 7 online (16 April 2018): (Another) special CROI issue

Third set of reports from CROI: pregnancy, adolescent care, drug interactions and side effects…

HTB: issue 6 online (30 March 2018): Special CROI issue

CROI reports: ibalizumab, pregnancy and review cure studies

HTB: issue 5 online (14 March 2018): Special CROI issue

CROI reports: bictegravir, PrEP and TB reports, plus cure-related research

Conference on Retroviruses and Opportunistic Infections (CROI 2018)

First reports: cure studies, new drugs for PrEP and HIV, breaking news for TB care…

HTB: issue 4 online (23 February 2018)

Looking ahead to CROI 2018, global use of dolutegravir, challenges of being transgender and positive…

HTB: issue 3 online (09 February 2018)

New drug approvals, HIV and pregnancy, guidelines and online resources…

London clinic to prescribe generic PrEP privately at £55 for 30 tablets

Simon Collins, HIV i-Base On 10 February 2018, the sexual health clinic at 56 Dean Street in Soho launched a new programme that will provide generic tenofovir DF/emtricitabine, the dual pill that protects against HIV. This will use private prescriptions in …

Featured i-Base 2018 appeal: we need your help…

£4.50 or £9.00 each month will support services this year…

Featured HTB: issue 2 online (22 January 2018)

UK HIV statistics, IMPACT PrEP trial, US guidelines drop use of “HIV infected”…

Post navigation